img

Global and United States Sterile Formulation Development Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and United States Sterile Formulation Development Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Sterile Formulation Development Market
This report focuses on global and United States Sterile Formulation Development market, also covers the segmentation data of other regions in regional level and county level.
The global Sterile Formulation Development revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Sterile Formulation Development revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Sterile Formulation Development include Dalton Pharma Services, PCI Pharma Services, Bioprocess Online, Farbe Firma, Anglo Bio-Pharma Limited, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions and Ardena, etc. The global five biggest players hold a share of % in 2023.
Global Sterile Formulation Development Scope and Market Size
Sterile Formulation Development market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Sterile Formulation Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Sterile Formulation Development market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Dalton Pharma Services
PCI Pharma Services
Bioprocess Online
Farbe Firma
Anglo Bio-Pharma Limited
Thermo Fisher Scientific
Pfizer CentreOne
Piramal Pharma Solutions
Ardena
Curida
Curia Global
Carbogen Amcis
Woodstock Sterile Solutions
Cambrex
Aenova Group
Lonza
Catalent
PPD
Althea
Baxter
Segment by Type
Liquid Dosage Form
Lyophilized Dosage Form
Frozen Dosage Form
Others

Segment by Application


Preclinical
Clinical
Commercial
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Sterile Formulation Development definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Sterile Formulation Development companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Sterile Formulation Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sterile Formulation Development revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Sterile Formulation Development Product Introduction
1.2 Global Sterile Formulation Development Outlook 2018 VS 2023 VS 2033
1.2.1 Global Sterile Formulation Development Market Size for the Year 2018-2033
1.2.2 United States Sterile Formulation Development Market Size for the Year 2018-2033
1.3 Sterile Formulation Development Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of United States Sterile Formulation Development in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Sterile Formulation Development Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.4 Sterile Formulation Development Market Dynamics
1.4.1 Sterile Formulation Development Industry Trends
1.4.2 Sterile Formulation Development Market Drivers
1.4.3 Sterile Formulation Development Market Challenges
1.4.4 Sterile Formulation Development Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Sterile Formulation Development by Type
2.1 Sterile Formulation Development Market Segment by Type
2.1.1 Liquid Dosage Form
2.1.2 Lyophilized Dosage Form
2.1.3 Frozen Dosage Form
2.1.4 Others
2.2 Global Sterile Formulation Development Market Size by Type (2018, 2023 & 2033)
2.3 Global Sterile Formulation Development Market Size by Type (2018-2033)
2.4 United States Sterile Formulation Development Market Size by Type (2018, 2023 & 2033)
2.5 United States Sterile Formulation Development Market Size by Type (2018-2033)
3 Sterile Formulation Development by Application
3.1 Sterile Formulation Development Market Segment by Application
3.1.1 Preclinical
3.1.2 Clinical
3.1.3 Commercial
3.2 Global Sterile Formulation Development Market Size by Application (2018, 2023 & 2033)
3.3 Global Sterile Formulation Development Market Size by Application (2018-2033)
3.4 United States Sterile Formulation Development Market Size by Application (2018, 2023 & 2033)
3.5 United States Sterile Formulation Development Market Size by Application (2018-2033)
4 Global Sterile Formulation Development Competitor Landscape by Company
4.1 Global Sterile Formulation Development Market Size by Company
4.1.1 Global Key Companies of Sterile Formulation Development, Ranked by Revenue (2023)
4.1.2 Global Sterile Formulation Development Revenue by Player (2018-2023)
4.2 Global Sterile Formulation Development Concentration Ratio (CR)
4.2.1 Sterile Formulation Development Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Sterile Formulation Development in 2023
4.2.3 Global Sterile Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Sterile Formulation Development Head office and Area Served
4.4 Global Key Players of Sterile Formulation Development, Product and Application
4.5 Global Key Players of Sterile Formulation Development, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Sterile Formulation Development Market Size by Company
4.7.1 Key Players of Sterile Formulation Development in United States, Ranked by Revenue (2023)
4.7.2 United States Sterile Formulation Development Revenue by Players (2021, 2023 & 2023)
5 Global Sterile Formulation Development Market Size by Region
5.1 Global Sterile Formulation Development Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Sterile Formulation Development Market Size by Region (2018-2033)
5.2.1 Global Sterile Formulation Development Market Size by Region: 2018-2023
5.2.2 Global Sterile Formulation Development Market Size by Region (2024-2033)
6 Americas
6.1 Americas Sterile Formulation Development Market Size YoY Growth 2018-2033
6.2 Americas Sterile Formulation Development Market Size by Type
6.2.1 Americas Sterile Formulation Development Market Size by Type (2018-2023)
6.2.2 Americas Sterile Formulation Development Market Size by Type (2024-2033)
6.2.3 Americas Sterile Formulation Development Market Share by Type (2018-2033)
6.3 Americas Sterile Formulation Development Market Size by Application
6.3.1 Americas Sterile Formulation Development Market Size by Application (2018-2023)
6.3.2 Americas Sterile Formulation Development Market Size by Application (2024-2033)
6.3.3 Americas Sterile Formulation Development Market Share by Application (2018-2033)
6.4 Americas Sterile Formulation Development Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Sterile Formulation Development Market Size YoY Growth 2018-2033
7.2 EMEA Sterile Formulation Development Market Size by Type
7.2.1 EMEA Sterile Formulation Development Market Size by Type (2018-2023)
7.2.2 EMEA Sterile Formulation Development Market Size by Type (2024-2033)
7.2.3 EMEA Sterile Formulation Development Market Share by Type (2018-2033)
7.3 EMEA Sterile Formulation Development Market Size by Application
7.3.1 EMEA Sterile Formulation Development Market Size by Application (2018-2023)
7.3.2 EMEA Sterile Formulation Development Market Size by Application (2024-2033)
7.3.3 EMEA Sterile Formulation Development Market Share by Application (2018-2033)
7.4 EMEA Sterile Formulation Development Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Sterile Formulation Development Market Size YoY Growth 2018-2033
8.2 China Sterile Formulation Development Market Size by Type
8.2.1 China Sterile Formulation Development Market Size by Type (2018-2023)
8.2.2 China Sterile Formulation Development Market Size by Type (2024-2033)
8.2.3 China Sterile Formulation Development Market Share by Type (2018-2033)
8.3 China Sterile Formulation Development Market Size by Application
8.3.1 China Sterile Formulation Development Market Size by Application (2018-2023)
8.3.2 China Sterile Formulation Development Market Size by Application (2024-2033)
8.3.3 China Sterile Formulation Development Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Sterile Formulation Development Market Size YoY Growth 2018-2033
9.2 APAC Sterile Formulation Development Market Size by Type
9.2.1 APAC Sterile Formulation Development Market Size by Type (2018-2023)
9.2.2 APAC Sterile Formulation Development Market Size by Type (2024-2033)
9.2.3 APAC Sterile Formulation Development Market Share by Type (2018-2033)
9.3 APAC Sterile Formulation Development Market Size by Application
9.3.1 APAC Sterile Formulation Development Market Size by Application (2018-2023)
9.3.2 APAC Sterile Formulation Development Market Size by Application (2024-2033)
9.3.3 APAC Sterile Formulation Development Market Share by Application (2018-2033)
9.4 APAC Sterile Formulation Development Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Dalton Pharma Services
10.1.1 Dalton Pharma Services Company Details
10.1.2 Dalton Pharma Services Business Overview
10.1.3 Dalton Pharma Services Sterile Formulation Development Introduction
10.1.4 Dalton Pharma Services Revenue in Sterile Formulation Development Business (2018-2023)
10.1.5 Dalton Pharma Services Recent Development
10.2 PCI Pharma Services
10.2.1 PCI Pharma Services Company Details
10.2.2 PCI Pharma Services Business Overview
10.2.3 PCI Pharma Services Sterile Formulation Development Introduction
10.2.4 PCI Pharma Services Revenue in Sterile Formulation Development Business (2018-2023)
10.2.5 PCI Pharma Services Recent Development
10.3 Bioprocess Online
10.3.1 Bioprocess Online Company Details
10.3.2 Bioprocess Online Business Overview
10.3.3 Bioprocess Online Sterile Formulation Development Introduction
10.3.4 Bioprocess Online Revenue in Sterile Formulation Development Business (2018-2023)
10.3.5 Bioprocess Online Recent Development
10.4 Farbe Firma
10.4.1 Farbe Firma Company Details
10.4.2 Farbe Firma Business Overview
10.4.3 Farbe Firma Sterile Formulation Development Introduction
10.4.4 Farbe Firma Revenue in Sterile Formulation Development Business (2018-2023)
10.4.5 Farbe Firma Recent Development
10.5 Anglo Bio-Pharma Limited
10.5.1 Anglo Bio-Pharma Limited Company Details
10.5.2 Anglo Bio-Pharma Limited Business Overview
10.5.3 Anglo Bio-Pharma Limited Sterile Formulation Development Introduction
10.5.4 Anglo Bio-Pharma Limited Revenue in Sterile Formulation Development Business (2018-2023)
10.5.5 Anglo Bio-Pharma Limited Recent Development
10.6 Thermo Fisher Scientific
10.6.1 Thermo Fisher Scientific Company Details
10.6.2 Thermo Fisher Scientific Business Overview
10.6.3 Thermo Fisher Scientific Sterile Formulation Development Introduction
10.6.4 Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (2018-2023)
10.6.5 Thermo Fisher Scientific Recent Development
10.7 Pfizer CentreOne
10.7.1 Pfizer CentreOne Company Details
10.7.2 Pfizer CentreOne Business Overview
10.7.3 Pfizer CentreOne Sterile Formulation Development Introduction
10.7.4 Pfizer CentreOne Revenue in Sterile Formulation Development Business (2018-2023)
10.7.5 Pfizer CentreOne Recent Development
10.8 Piramal Pharma Solutions
10.8.1 Piramal Pharma Solutions Company Details
10.8.2 Piramal Pharma Solutions Business Overview
10.8.3 Piramal Pharma Solutions Sterile Formulation Development Introduction
10.8.4 Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (2018-2023)
10.8.5 Piramal Pharma Solutions Recent Development
10.9 Ardena
10.9.1 Ardena Company Details
10.9.2 Ardena Business Overview
10.9.3 Ardena Sterile Formulation Development Introduction
10.9.4 Ardena Revenue in Sterile Formulation Development Business (2018-2023)
10.9.5 Ardena Recent Development
10.10 Curida
10.10.1 Curida Company Details
10.10.2 Curida Business Overview
10.10.3 Curida Sterile Formulation Development Introduction
10.10.4 Curida Revenue in Sterile Formulation Development Business (2018-2023)
10.10.5 Curida Recent Development
10.11 Curia Global
10.11.1 Curia Global Company Details
10.11.2 Curia Global Business Overview
10.11.3 Curia Global Sterile Formulation Development Introduction
10.11.4 Curia Global Revenue in Sterile Formulation Development Business (2018-2023)
10.11.5 Curia Global Recent Development
10.12 Carbogen Amcis
10.12.1 Carbogen Amcis Company Details
10.12.2 Carbogen Amcis Business Overview
10.12.3 Carbogen Amcis Sterile Formulation Development Introduction
10.12.4 Carbogen Amcis Revenue in Sterile Formulation Development Business (2018-2023)
10.12.5 Carbogen Amcis Recent Development
10.13 Woodstock Sterile Solutions
10.13.1 Woodstock Sterile Solutions Company Details
10.13.2 Woodstock Sterile Solutions Business Overview
10.13.3 Woodstock Sterile Solutions Sterile Formulation Development Introduction
10.13.4 Woodstock Sterile Solutions Revenue in Sterile Formulation Development Business (2018-2023)
10.13.5 Woodstock Sterile Solutions Recent Development
10.14 Cambrex
10.14.1 Cambrex Company Details
10.14.2 Cambrex Business Overview
10.14.3 Cambrex Sterile Formulation Development Introduction
10.14.4 Cambrex Revenue in Sterile Formulation Development Business (2018-2023)
10.14.5 Cambrex Recent Development
10.15 Aenova Group
10.15.1 Aenova Group Company Details
10.15.2 Aenova Group Business Overview
10.15.3 Aenova Group Sterile Formulation Development Introduction
10.15.4 Aenova Group Revenue in Sterile Formulation Development Business (2018-2023)
10.15.5 Aenova Group Recent Development
10.16 Lonza
10.16.1 Lonza Company Details
10.16.2 Lonza Business Overview
10.16.3 Lonza Sterile Formulation Development Introduction
10.16.4 Lonza Revenue in Sterile Formulation Development Business (2018-2023)
10.16.5 Lonza Recent Development
10.17 Catalent
10.17.1 Catalent Company Details
10.17.2 Catalent Business Overview
10.17.3 Catalent Sterile Formulation Development Introduction
10.17.4 Catalent Revenue in Sterile Formulation Development Business (2018-2023)
10.17.5 Catalent Recent Development
10.18 PPD
10.18.1 PPD Company Details
10.18.2 PPD Business Overview
10.18.3 PPD Sterile Formulation Development Introduction
10.18.4 PPD Revenue in Sterile Formulation Development Business (2018-2023)
10.18.5 PPD Recent Development
10.19 Althea
10.19.1 Althea Company Details
10.19.2 Althea Business Overview
10.19.3 Althea Sterile Formulation Development Introduction
10.19.4 Althea Revenue in Sterile Formulation Development Business (2018-2023)
10.19.5 Althea Recent Development
10.20 Baxter
10.20.1 Baxter Company Details
10.20.2 Baxter Business Overview
10.20.3 Baxter Sterile Formulation Development Introduction
10.20.4 Baxter Revenue in Sterile Formulation Development Business (2018-2023)
10.20.5 Baxter Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Sterile Formulation Development Market Size United States VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Sterile Formulation Development Market Trends
Table 3. Sterile Formulation Development Market Drivers
Table 4. Sterile Formulation Development Market Challenges
Table 5. Sterile Formulation Development Market Restraints
Table 6. Global Sterile Formulation Development Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. United States Sterile Formulation Development Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Sterile Formulation Development Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. United States Sterile Formulation Development Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Sterile Formulation Development, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Sterile Formulation Development Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Sterile Formulation Development Revenue Share by Player, 2018-2023
Table 13. Global Sterile Formulation Development Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sterile Formulation Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Formulation Development as of 2023)
Table 15. Global Key Players of Sterile Formulation Development, Headquarters and Area Served
Table 16. Global Key Players of Sterile Formulation Development, Product and Application
Table 17. Global Key Players of Sterile Formulation Development, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Sterile Formulation Development in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Sterile Formulation Development Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. United States Sterile Formulation Development Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Sterile Formulation Development Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Sterile Formulation Development Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Sterile Formulation Development Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Sterile Formulation Development Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Sterile Formulation Development Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Sterile Formulation Development Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Sterile Formulation Development Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Sterile Formulation Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Sterile Formulation Development Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Sterile Formulation Development Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Sterile Formulation Development Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Sterile Formulation Development Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Sterile Formulation Development Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Sterile Formulation Development Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Sterile Formulation Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Sterile Formulation Development Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Sterile Formulation Development Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Sterile Formulation Development Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Sterile Formulation Development Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Sterile Formulation Development Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Sterile Formulation Development Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Sterile Formulation Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Sterile Formulation Development Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Sterile Formulation Development Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Sterile Formulation Development Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Sterile Formulation Development Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Sterile Formulation Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Sterile Formulation Development Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Sterile Formulation Development Market Size by Region (2024-2033) & (US$ Million)
Table 51. Dalton Pharma Services Company Details
Table 52. Dalton Pharma Services Business Overview
Table 53. Dalton Pharma Services Sterile Formulation Development Product
Table 54. Dalton Pharma Services Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 55. Dalton Pharma Services Recent Development
Table 56. PCI Pharma Services Company Details
Table 57. PCI Pharma Services Business Overview
Table 58. PCI Pharma Services Sterile Formulation Development Product
Table 59. PCI Pharma Services Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 60. PCI Pharma Services Recent Development
Table 61. Bioprocess Online Company Details
Table 62. Bioprocess Online Business Overview
Table 63. Bioprocess Online Sterile Formulation Development Product
Table 64. Bioprocess Online Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 65. Bioprocess Online Recent Development
Table 66. Farbe Firma Company Details
Table 67. Farbe Firma Business Overview
Table 68. Farbe Firma Sterile Formulation Development Product
Table 69. Farbe Firma Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 70. Farbe Firma Recent Development
Table 71. Anglo Bio-Pharma Limited Company Details
Table 72. Anglo Bio-Pharma Limited Business Overview
Table 73. Anglo Bio-Pharma Limited Sterile Formulation Development Product
Table 74. Anglo Bio-Pharma Limited Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 75. Anglo Bio-Pharma Limited Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Sterile Formulation Development Product
Table 79. Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Pfizer CentreOne Company Details
Table 82. Pfizer CentreOne Business Overview
Table 83. Pfizer CentreOne Sterile Formulation Development Product
Table 84. Pfizer CentreOne Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 85. Pfizer CentreOne Recent Development
Table 86. Piramal Pharma Solutions Company Details
Table 87. Piramal Pharma Solutions Business Overview
Table 88. Piramal Pharma Solutions Sterile Formulation Development Product
Table 89. Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 90. Piramal Pharma Solutions Recent Development
Table 91. Ardena Company Details
Table 92. Ardena Business Overview
Table 93. Ardena Sterile Formulation Development Product
Table 94. Ardena Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 95. Ardena Recent Development
Table 96. Curida Company Details
Table 97. Curida Business Overview
Table 98. Curida Sterile Formulation Development Product
Table 99. Curida Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 100. Curida Recent Development
Table 101. Curia Global Company Details
Table 102. Curia Global Business Overview
Table 103. Curia Global Sterile Formulation Development Product
Table 104. Curia Global Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 105. Curia Global Recent Development
Table 106. Carbogen Amcis Company Details
Table 107. Carbogen Amcis Business Overview
Table 108. Carbogen Amcis Sterile Formulation Development Product
Table 109. Carbogen Amcis Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 110. Carbogen Amcis Recent Development
Table 111. Woodstock Sterile Solutions Company Details
Table 112. Woodstock Sterile Solutions Business Overview
Table 113. Woodstock Sterile Solutions Sterile Formulation Development Product
Table 114. Woodstock Sterile Solutions Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 115. Woodstock Sterile Solutions Recent Development
Table 116. Cambrex Company Details
Table 117. Cambrex Business Overview
Table 118. Cambrex Sterile Formulation Development Product
Table 119. Cambrex Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 120. Cambrex Recent Development
Table 121. Aenova Group Company Details
Table 122. Aenova Group Business Overview
Table 123. Aenova Group Sterile Formulation Development Product
Table 124. Aenova Group Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 125. Aenova Group Recent Development
Table 126. Lonza Company Details
Table 127. Lonza Business Overview
Table 128. Lonza Sterile Formulation Development Product
Table 129. Lonza Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 130. Lonza Recent Development
Table 131. Catalent Company Details
Table 132. Catalent Business Overview
Table 133. Catalent Sterile Formulation Development Product
Table 134. Catalent Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 135. Catalent Recent Development
Table 136. PPD Company Details
Table 137. PPD Business Overview
Table 138. PPD Sterile Formulation Development Product
Table 139. PPD Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 140. PPD Recent Development
Table 141. Althea Company Details
Table 142. Althea Business Overview
Table 143. Althea Sterile Formulation Development Product
Table 144. Althea Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 145. Althea Recent Development
Table 146. Baxter Company Details
Table 147. Baxter Business Overview
Table 148. Baxter Sterile Formulation Development Product
Table 149. Baxter Revenue in Sterile Formulation Development Business (2018-2023) & (US$ Million)
Table 150. Baxter Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Sterile Formulation Development Product Picture
Figure 2. Global Sterile Formulation Development Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Sterile Formulation Development Market Size 2018-2033 (US$ Million)
Figure 4. United States Sterile Formulation Development Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. United States Sterile Formulation Development Market Size 2018-2033 (US$ Million)
Figure 6. United States Sterile Formulation Development Market Share in Global 2018-2033
Figure 7. Sterile Formulation Development Report Years Considered
Figure 8. Product Picture of Liquid Dosage Form
Figure 9. Product Picture of Lyophilized Dosage Form
Figure 10. Product Picture of Frozen Dosage Form
Figure 11. Product Picture of Others
Figure 12. Global Sterile Formulation Development Market Share by Type in 2023 & 2033
Figure 13. Global Sterile Formulation Development Market Size by Type (2018-2033) & (US$ Million)
Figure 14. Global Sterile Formulation Development Market Share by Type (2018-2033)
Figure 15. United States Sterile Formulation Development Market Share by Type in 2023 & 2033
Figure 16. United States Sterile Formulation Development Market Size by Type (2018-2033) & (US$ Million)
Figure 17. United States Sterile Formulation Development Market Share by Type (2018-2033)
Figure 18. Product Picture of Preclinical
Figure 19. Product Picture of Clinical
Figure 20. Product Picture of Commercial
Figure 21. Global Sterile Formulation Development Market Share by Application in 2023 & 2033
Figure 22. Global Sterile Formulation Development Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Sterile Formulation Development Market Share by Application (2018-2033)
Figure 24. United States Sterile Formulation Development Market Share by Application in 2023 & 2033
Figure 25. United States Sterile Formulation Development Market Size by Application (2018-2033) & (US$ Million)
Figure 26. United States Sterile Formulation Development Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Sterile Formulation Development in the World: Market Share by Sterile Formulation Development Revenue in 2023
Figure 28. Global Sterile Formulation Development Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 29. Global Sterile Formulation Development Market Share by Region (2018-2033)
Figure 30. Americas Sterile Formulation Development Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Sterile Formulation Development Market Share by Type (2018-2033)
Figure 32. Americas Sterile Formulation Development Market Share by Application (2018-2033)
Figure 33. United States Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Sterile Formulation Development Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Sterile Formulation Development Market Share by Type (2018-2033)
Figure 39. EMEA Sterile Formulation Development Market Share by Application (2018-2033)
Figure 40. Europe Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Sterile Formulation Development Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Sterile Formulation Development Market Share by Type (2018-2033)
Figure 45. China Sterile Formulation Development Market Share by Application (2018-2033)
Figure 46. APAC Sterile Formulation Development Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Sterile Formulation Development Market Share by Type (2018-2033)
Figure 48. APAC Sterile Formulation Development Market Share by Application (2018-2033)
Figure 49. Japan Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Sterile Formulation Development Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. Dalton Pharma Services Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 55. PCI Pharma Services Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 56. Bioprocess Online Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 57. Farbe Firma Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 58. Anglo Bio-Pharma Limited Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 60. Pfizer CentreOne Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 61. Piramal Pharma Solutions Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 62. Ardena Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 63. Curida Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 64. Curia Global Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 65. Carbogen Amcis Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 66. Woodstock Sterile Solutions Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 67. Cambrex Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 68. Aenova Group Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 69. Lonza Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 70. Catalent Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 71. PPD Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 72. Althea Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 73. Baxter Revenue Growth Rate in Sterile Formulation Development Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries